Skip to main content

and
  1. No Access

    Article

    Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation

    Antibodies targeting the T-cell immune checkpoint cytotoxic T-lymphocyte antigen-4 (CTLA4) enhance the effectiveness of radiotherapy for melanoma patients, but many remain resistant. To further improve respons...

    Anthony L. Schwartz, Pulak R. Nath, Michael Allgauer in Cancer Immunology, Immunotherapy (2019)

  2. Article

    Open Access

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

    Andreas Lundqvist, Vincent van Hoef, **aonan Zhang in Journal for ImmunoTherapy of Cancer (2016)

  3. Article

    Open Access

    Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors

    Jenny H Pan, Suman Vodnala, Robert L Eil, Zhiya Yu in Journal for ImmunoTherapy of Cancer (2015)

  4. Article

    Open Access

    Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma

    Joal D Beane, Gary K Lee, Zhili Zheng in Journal for ImmunoTherapy of Cancer (2014)

  5. Article

    Open Access

    Engineering the immune response to "self" for effective cancer immunotherapy

    Shi Zhong, Karolina Malecek, Duane Moogk in Journal for ImmunoTherapy of Cancer (2014)

  6. Article

    Open Access

    T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy

    Michelle Krogsgaard, Shi Zhong, Karolina Malecek in Journal for ImmunoTherapy of Cancer (2013)

  7. No Access

    Article

    Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

    The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric antigen receptors is a promising approach for the adoptive cell therapy of patients with cancer. We previously devel...

    Shicheng Yang, Yun Ji, Luca Gattinoni, Ling Zhang in Cancer Immunology, Immunotherapy (2013)

  8. Article

    Open Access

    Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

    Oncolytic viral therapy represents an alternative therapeutic strategy for the treatment of cancer. We previously described GLV-1h68, a modified Vaccinia Virus with exclusive tropism for tumor cells, and we ob...

    Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, Sharon Adams in BMC Cancer (2011)

  9. Article

    Erratum to: In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells

    Shicheng Yang, Luca Gattinoni, Fang Liu, Yun Ji in Cancer Immunology, Immunotherapy (2011)

  10. No Access

    Article

    In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells

    The T-lymphocyte pool can be subdivided into naïve (Tn), effector memory (Tem), and central memory (Tcm) T cells. In this study, we characterized in vitro short-term cultured anti-tumor human T lymphocytes gen...

    Shicheng Yang, Gattinoni Luca, Fang Liu, Yun Ji in Cancer Immunology, Immunotherapy (2011)